Clinical Trial Update: Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine for preventing SARS-CoV-2 infection and reducing COVID-19 severity during pregnancy and postpartum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 in Pregnancy

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Barcelona Institute for Global Health | Conditions: Pregnancy Related, COVID | Phase 3 | Status: COMPLETED